Labatec Pharma announces an exclusive licensing agreement signed with AFT Pharmaceuticals, to commercialise MAXIGESIC IV®, in Switzerland
29 mars 2023
Would you like to discuss a collaboration or partnership project? Get in touch with us at partnering@labatec.com or connect with us at one of the upcoming events.
Pour toute autre demande, nous vous invitons à consulter notre page de contacts. contact page.